• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔舌鳞状细胞癌合并糖尿病患者的复发率较低,生存率提高:对治疗的启示

Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: Implications for treatment.

作者信息

Salehi Amir M, Wang Lixiao, Gu Xiaolian, Coates Philip J, Norberg Spaak Lena, Sgaramella Nicola, Nylander Karin

机构信息

Department of Medical Biosciences/Pathology, Umeå University, SE 901 85 Umeå, Sweden.

Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno 656 53, Czech Republic.

出版信息

Oncol Lett. 2024 Feb 6;27(4):142. doi: 10.3892/ol.2024.14275. eCollection 2024 Apr.

DOI:10.3892/ol.2024.14275
PMID:38385115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10877229/
Abstract

Locoregional recurrences and distant metastases are major problems for patients with squamous cell carcinoma of the head and neck (SCCHN). Because SCCHN is a heterogeneous group of tumours with varying characteristics, the present study concentrated on the subgroup of squamous cell carcinoma of the oral tongue (SCCOT) to investigate the use of machine learning approaches to predict the risk of recurrence from routine clinical data available at diagnosis. The approach also identified the most important parameters that identify and classify recurrence risk. A total of 66 patients with SCCOT were included. Clinical data available at diagnosis were analysed using statistical analysis and machine learning approaches. Tumour recurrence was associated with T stage (P=0.001), radiological neck metastasis (P=0.010) and diabetes (P=0.003). A machine learning model based on the random forest algorithm and with attendant explainability was used. Whilst patients with diabetes were overrepresented in the SCCOT cohort, diabetics had lower recurrence rates (P=0.015 after adjusting for age and other clinical features) and an improved 2-year survival (P=0.025) compared with non-diabetics. Clinical, radiological and histological data available at diagnosis were used to establish a prognostic model for patients with SCCOT. Using machine learning to predict recurrence produced a classification model with 71.2% accuracy. Notably, one of the findings of the feature importance rankings of the model was that diabetics exhibited less recurrence and improved survival compared with non-diabetics, even after accounting for the independent prognostic variables of tumour size and patient age at diagnosis. These data imply that the therapeutic manipulation of glucose levels used to treat diabetes may be useful for patients with SCCOT regardless of their diabetic status. Further studies are warranted to investigate the impact of diabetes in other SCCHN subtypes.

摘要

局部区域复发和远处转移是头颈部鳞状细胞癌(SCCHN)患者面临的主要问题。由于SCCHN是一组具有不同特征的异质性肿瘤,本研究聚焦于舌鳞状细胞癌(SCCOT)亚组,以探讨使用机器学习方法从诊断时可用的常规临床数据预测复发风险。该方法还确定了识别和分类复发风险的最重要参数。共纳入66例SCCOT患者。使用统计分析和机器学习方法对诊断时可用的临床数据进行分析。肿瘤复发与T分期(P=0.001)、颈部影像学转移(P=0.010)和糖尿病(P=0.003)相关。使用了基于随机森林算法且具有伴随可解释性的机器学习模型。虽然SCCOT队列中糖尿病患者比例过高,但与非糖尿病患者相比,糖尿病患者的复发率较低(在调整年龄和其他临床特征后P=0.015),且2年生存率有所提高(P=0.025)。利用诊断时可用的临床、影像学和组织学数据为SCCOT患者建立了一个预后模型。使用机器学习预测复发产生了一个准确率为71.2%的分类模型。值得注意的是,该模型特征重要性排名的一项发现是,即使在考虑了肿瘤大小和诊断时患者年龄等独立预后变量后,糖尿病患者与非糖尿病患者相比仍表现出较少的复发和更好的生存率。这些数据表明,用于治疗糖尿病的血糖水平治疗性调控可能对SCCOT患者有用,无论其糖尿病状态如何。有必要进一步研究糖尿病在其他SCCHN亚型中的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/ed2aa91b416d/ol-27-04-14275-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/ae8c35276e7c/ol-27-04-14275-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/88a620811b44/ol-27-04-14275-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/ed2aa91b416d/ol-27-04-14275-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/ae8c35276e7c/ol-27-04-14275-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/88a620811b44/ol-27-04-14275-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ad6/10877229/ed2aa91b416d/ol-27-04-14275-g02.jpg

相似文献

1
Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: Implications for treatment.口腔舌鳞状细胞癌合并糖尿病患者的复发率较低,生存率提高:对治疗的启示
Oncol Lett. 2024 Feb 6;27(4):142. doi: 10.3892/ol.2024.14275. eCollection 2024 Apr.
2
Metastasis of squamous cell carcinoma of the oral tongue.舌鳞状细胞癌的转移
Cancer Metastasis Rev. 2007 Dec;26(3-4):645-62. doi: 10.1007/s10555-007-9082-y.
3
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.年轻成人舌鳞状细胞癌的新辅助化疗:病例系列
Head Neck. 2005 Sep;27(9):748-56. doi: 10.1002/hed.20240.
4
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.含西妥昔单抗方案治疗局部区域性复发和远处转移性头颈部鳞状细胞癌的疗效。
BMC Cancer. 2022 Dec 20;22(1):1336. doi: 10.1186/s12885-022-10440-7.
5
Levels of MUC1 in tumours and serum of patients with different sub-types of squamous cell carcinoma of the head and neck.头颈部不同亚型鳞状细胞癌患者肿瘤组织和血清中MUC1的水平。
Oncol Lett. 2020 Aug;20(2):1709-1718. doi: 10.3892/ol.2020.11746. Epub 2020 Jun 17.
6
High Failure Rates in Young Nonsmoker Nondrinkers With Squamous Cell Carcinoma of the Oral Tongue.年轻非吸烟非饮酒的口腔舌部鳞状细胞癌患者的高失败率。
Laryngoscope. 2023 May;133(5):1110-1121. doi: 10.1002/lary.30253. Epub 2022 Jun 18.
7
Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.115例T1-T2期口腔鳞状细胞癌患者的临床病理参数、复发情况、局部区域及远处转移情况
Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.
8
Early detection of squamous cell carcinoma of the oral tongue using multidimensional plasma protein analysis and interpretable machine learning.采用多维血浆蛋白分析和可解释机器学习技术早期检测舌鳞状细胞癌。
J Oral Pathol Med. 2023 Aug;52(7):637-643. doi: 10.1111/jop.13461. Epub 2023 Jul 10.
9
Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment.年轻患者口腔舌鳞状细胞癌:治疗结果及意义
Indian J Surg Oncol. 2020 Jun;11(2):274-280. doi: 10.1007/s13193-020-01049-y. Epub 2020 Feb 22.
10
Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue.包膜外扩散。舌鳞状细胞癌患者治疗失败的一个重要预测因素。
Cancer. 2001 Dec 15;92(12):3030-6. doi: 10.1002/1097-0142(20011215)92:12<3030::aid-cncr10148>3.0.co;2-p.

引用本文的文献

1
A review on diabetes and oral cancer: Molecular links and implications.糖尿病与口腔癌综述:分子联系及影响
Mol Biol Res Commun. 2025;14(2):109-113. doi: 10.22099/mbrc.2024.51225.2042.
2
A novel nomogram for predicting overall survival in patients with tongue squamous cell carcinoma using clinical features and MRI radiomics data: a pilot study.一种基于临床特征和 MRI 放射组学数据预测舌鳞癌患者总生存的新型列线图:一项初步研究。
World J Surg Oncol. 2024 Aug 29;22(1):227. doi: 10.1186/s12957-024-03508-0.

本文引用的文献

1
Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP.基于 LIME 和 SHAP 的机器学习在鼻咽癌生存分析中的可解释性。
Sci Rep. 2023 Jun 2;13(1):8984. doi: 10.1038/s41598-023-35795-0.
2
Evaluating Metformin Strategies for Cancer Prevention: A Target Trial Emulation Using Electronic Health Records.评估二甲双胍在癌症预防中的策略:基于电子健康记录的目标试验模拟。
Epidemiology. 2023 Sep 1;34(5):690-699. doi: 10.1097/EDE.0000000000001626. Epub 2023 May 23.
3
Blood metabolic biomarkers and the risk of head and neck cancer: An epidemiological study in the Swedish AMORIS Cohort.
血液代谢生物标志物与头颈癌风险:瑞典AMORIS队列的一项流行病学研究
Cancer Lett. 2023 Mar 31;557:216091. doi: 10.1016/j.canlet.2023.216091. Epub 2023 Feb 8.
4
Measuring the Usability and Quality of Explanations of a Machine Learning Web-Based Tool for Oral Tongue Cancer Prognostication.测量基于 Web 的机器学习工具对口腔舌癌预后解释的可用性和质量。
Int J Environ Res Public Health. 2022 Jul 8;19(14):8366. doi: 10.3390/ijerph19148366.
5
Deep Machine Learning for Oral Cancer: From Precise Diagnosis to Precision Medicine.用于口腔癌的深度机器学习:从精确诊断到精准医疗。
Front Oral Health. 2022 Jan 11;2:794248. doi: 10.3389/froh.2021.794248. eCollection 2021.
6
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.雷帕霉素靶蛋白信号通路抑制和二甲双胍在口腔癌前病变中的临床活性。
JCI Insight. 2021 Sep 8;6(17):e147096. doi: 10.1172/jci.insight.147096.
7
Glycolysis-induced drug resistance in tumors-A response to danger signals?肿瘤糖酵解诱导的耐药性——对危险信号的反应?
Neoplasia. 2021 Feb;23(2):234-245. doi: 10.1016/j.neo.2020.12.009. Epub 2021 Jan 6.
8
The predictive power of CD3 T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.CD3 阳性 T 细胞浸润对口腔鳞状细胞肿瘤的预测能力仅限于非糖尿病患者。
Cancer Lett. 2021 Feb 28;499:209-219. doi: 10.1016/j.canlet.2020.11.029. Epub 2020 Dec 1.
9
Could ketogenic diet "starve" cancer? Emerging evidence.生酮饮食能否“饿死”肿瘤?新的证据。
Crit Rev Food Sci Nutr. 2022;62(7):1800-1821. doi: 10.1080/10408398.2020.1847030. Epub 2020 Dec 4.
10
Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck.转运RNA衍生片段是头颈部鳞状细胞癌患者潜在的预后因素。
Genes (Basel). 2020 Nov 13;11(11):1344. doi: 10.3390/genes11111344.